Sugi Predict

Sugi Predict / Compounds / SCHEMBL33666

SCHEMBL33666

SCHEMBL33666

Cc1cccc([N+](=O)[O-])c1C(=O)O

nearest known ligand 1.00 ✓ in ChEMBL — recovers established targets

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
▸ TDP1 Q9NUW8 4/20 1.00
▸ L3MBTL1 Q9Y468 1/20 1.00
▸ TSHR P16473 5/20 0.59
▸ SMN1; SMN2 Q16637 1/20 0.58
▸ HSD17B10 Q99714 1/20 0.57
▸ ALDH1A1 P00352 1/20 0.48
▸ GPR35 Q9HC97 1/20 0.48
▸ POLB P06746 2/20 0.47
▸ MEN1 O00255 1/20 0.47
▸ KMT2A Q03164 1/20 0.47
▸ KCNMA1 Q12791 1/20 0.46
▸ CES2 O00748 1/20 0.45
▸ CES1 P23141 1/20 0.45
▸ CRHBP P24387 1/20 0.44
▸ CRHR2 Q13324 1/20 0.44
▸ LMNA P02545 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1585523 1.00 TDP1 (1.00) TDP1L3MBTL1TSHRSMN1; SMN2HSD17B10
SCHEMBL28224261 0.89 TSHR (0.79) TDP1L3MBTL1TSHRSMN1; SMN2HSD17B10
SCHEMBL1554602 0.86 TDP1 (0.75) TDP1L3MBTL1TSHRALDH1A1GPR35
SCHEMBL5725578 0.85 TDP1 (0.74) TDP1L3MBTL1TSHRSMN1; SMN2HSD17B10
SCHEMBL1476531 0.85 TDP1 (0.74) TDP1L3MBTL1TSHRSMN1; SMN2HSD17B10
SCHEMBL4687664 0.84 TDP1 (0.73) TDP1L3MBTL1TSHRSMN1; SMN2HSD17B10
SCHEMBL28180673 0.84 TSHR (0.71) TDP1L3MBTL1TSHRSMN1; SMN2ALDH1A1
Potassium Ion SCHEMBL15876228 0.84 TDP1 (0.72) TDP1L3MBTL1TSHRSMN1; SMN2HSD17B10
SCHEMBL31151600 0.84 TDP1 (0.72) TDP1L3MBTL1TSHRSMN1; SMN2HSD17B10
SCHEMBL1806108 0.84 TDP1 (0.72) TDP1L3MBTL1TSHRSMN1; SMN2HSD17B10

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 835 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-118702482-A Preparation method of sintered artificial marble 广西大学 2024-09-27 — — CN claimed
CN-114249533-B Preparation method of graphene oxide glaze modified polished ceramic tile 广西蒙娜丽莎新材料有限公司 2023-12-19 — — CN claimed
CN-116836081-A Ether epoxy toughening agent and preparation method and application thereof 中国林业科学研究院林产化学工业研究所 2023-10-03 — — CN claimed
CN-116836061-A Method for separating mixed acid 绍兴贝斯美化工股份有限公司 2023-10-03 — — CN claimed
CN-115818959-A Method for reducing cost of glazing isolation glaze 广西蒙娜丽莎新材料有限公司 2023-03-21 — — CN claimed
CN-114195553-B Preparation method of fibrous nano-alumina modified ceramic glazed tile 广西蒙娜丽莎新材料有限公司 2022-09-30 — — CN claimed
CN-114249533-A Preparation method of graphene oxide glaze modified polished ceramic tile 广西蒙娜丽莎新材料有限公司 2022-03-29 — — CN claimed
CN-114195553-A Preparation method of fibrous nano-alumina modified ceramic glazed tile 广西蒙娜丽莎新材料有限公司 2022-03-18 — — CN claimed
CN-111362806-B Co-production method of 3-nitro-2-methylbenzoic acid and 3-nitrophthalic acid 江苏永安化工有限公司 2022-01-18 — — CN claimed
CN-111718264-B Method for co-producing 2-methyl-6-nitrobenzoic acid and 2-methyl-3-nitrobenzoic acid 江苏永安化工有限公司 2021-12-03 — — CN claimed
US-20060020141-A1 Metallized dye XEROX CORPORATION 2006-01-26 — — US claimed
US-20060016369-A1 PHASE CHANGE INKS XEROX CORPORATION 2006-01-26 — — US claimed
US-6946025-B2 Process for preparing tetra-amide compounds XEROX CORPORATION (US) 2005-09-20 — — US claimed
US-20050090690-A1 Process for preparing tetra-amide compounds XEROX CORPORATION 2005-04-28 — — US claimed
EP-0927714-B1 PROCESS FOR THE SEPARATION OF NITROTOLUIC ACID ISOMERS SUMIKIN CHEMICAL (JP) 2002-04-10 — — EP claimed
US-6054609-A ADDING AN AROMATIC ORGANIC BASE TO MIXTURE OF 3-NITRO-O-TOLUIC ACID AND 5-NITRO-O-TOLUIC ACID AND EFFICIENTLY RECOVERING BOTH 3-NITRO-O-TOLUIC ACID AND 5-NITRO-O-TOLUIC ACID BY TAKING ADVANTAGE OF DIFFERENCE BETWEEN IN THEIR SOLUBILITY TO WATER SUMIKIN CHEMICAL CO., LTD. (JP) 2000-04-25 — — US claimed
EP-0927714-A1 PROCESS FOR THE SEPARATION OF NITROTOLUIC ACID ISOMERS SUMIKIN CHEMICAL CO., LTD. (JP) 1999-07-07 — — EP claimed
EP-0519971-B1 NOVEL PHARMACEUTICALLY ACTIVE COMPOUNDS WHICH CAN BE FORMED FROM 1,3,4,6,7,8-HEXAHYDRO-2H-PYRIMIDO-(1,2-a)-PYRIMIDINE INST SOZIAL MED FORSCHUNG SA (CH) 1997-01-15 — — EP claimed
EP-0519971-A1 NOVEL PHARMACEUTICALLY ACTIVE COMPOUNDS WHICH CAN BE FORMED FROM 1,3,4,6,7,8-HEXAHYDRO-2H-PYRIMIDO-(1,2-a)-PYRIMIDINE. EEC PHARMA SA (FR) 1992-12-30 — — EP claimed
WO-1991013886-A1 NOVEL PHARMACEUTICALLY ACTIVE COMPOUNDS WHICH CAN BE FORMED FROM 1,3,4,6,7,8-HEXAHYDRO-2H-PYRIMIDO-(1,2-a)-PYRIMIDINE EEC-PHARMA S.A. (FR) 1991-09-19 — — WO claimed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20060020141-A1 Metallized dye CDYL, CDY1; CDY1B, CDYL2 TDP1 3338/4885L3MBTL1 598/4885TSHR 2894/4885
US-20050090690-A1 Process for preparing tetra-amide compounds TAF9, TAF5, TAF1 TDP1 1182/4885L3MBTL1 4695/4885TSHR 4082/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.